These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36450915)

  • 21. [Molecular pathology of malignant hyperthermia and central core disease].
    Takagi A
    Nihon Rinsho; 1997 Dec; 55(12):3307-14. PubMed ID: 9436456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
    Barrientos GC; Feng W; Truong K; Matthaei KI; Yang T; Allen PD; Lopez JR; Pessah IN
    J Biol Chem; 2012 Jan; 287(4):2863-76. PubMed ID: 22139840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells.
    Greer LK; Meilleur KG; Harvey BK; Wires ES
    Orphanet J Rare Dis; 2022 Jun; 17(1):225. PubMed ID: 35698232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.
    Kraeva N; Heytens L; Jungbluth H; Treves S; Voermans N; Kamsteeg E; Ceuterick-de Groote C; Baets J; Riazi S
    Neuromuscul Disord; 2015 Jul; 25(7):567-76. PubMed ID: 25958340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.
    De Crescenzo V; Fogarty KE; Lefkowitz JJ; Bellve KD; Zvaritch E; MacLennan DH; Walsh JV
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):610-5. PubMed ID: 22203976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
    Truong KM; Pessah IN
    Toxicol Sci; 2019 Feb; 167(2):509-523. PubMed ID: 30329129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.
    Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G
    J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca
    Murayama T; Kurebayashi N; Ishigami-Yuasa M; Mori S; Suzuki Y; Akima R; Ogawa H; Suzuki J; Kanemaru K; Oyamada H; Kiuchi Y; Iino M; Kagechika H; Sakurai T
    Mol Pharmacol; 2018 Jul; 94(1):722-730. PubMed ID: 29674523
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Zullo A; Perrotta G; D'Angelo R; Ruggiero L; Gravino E; Del Vecchio L; Santoro L; Salvatore F; Carsana A
    Biomed Res Int; 2019; 2019():7638946. PubMed ID: 31165076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?
    Dirksen RT; Avila G
    Trends Cardiovasc Med; 2002 Jul; 12(5):189-97. PubMed ID: 12161072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.
    Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G
    J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
    Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
    J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
    Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
    Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
    Dirksen RT; Avila G
    Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
    Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
    Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium dependent rescue of a myopathy with core-like structures in mouse.
    Hanson MG; Wilde JJ; Moreno RL; Minic AD; Niswander L
    Elife; 2015 Jan; 4():. PubMed ID: 25564733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex].
    Lunardi J; Monnier N
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S70-7. PubMed ID: 15269663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.